SCHEMBL25540377

SCHEMBL25540377

CC1(C)c2cc(-c3ccc(-c4nc(-c5ccccc5-c5ccccc5)cc(-c5cccc6ccccc56)n4)c4ccccc34)ccc2-c2cc3ccccc3cc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP3 O14638 1/20 0.38
ENPP1 P22413 1/20 0.38
PPARG P37231 8/20 0.36
PPARA Q07869 8/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
PPARD Q03181 1/20 0.36
CHRNA1 P02708 1/20 0.35
CHRNG P07510 1/20 0.35
CHRNB1 P11230 1/20 0.35
CHRNB2 P17787 1/20 0.35
SLC6A2 P23975 1/20 0.35
CHRNB4 P30926 1/20 0.35
SLC6A4 P31645 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA4 P43681 1/20 0.35
SLC6A3 Q01959 1/20 0.35
CHRND Q07001 1/20 0.35
MCL1 Q07820 1/20 0.35
ACMSD Q8TDX5 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25538212 1.00 ENPP3 (0.38) ENPP3ENPP1PPARGPPARACYP2C9
SCHEMBL25540445 0.96 ENPP3 (0.36) ENPP3ENPP1PPARGPPARACYP2C9
SCHEMBL25538340 0.96 ENPP3 (0.36) ENPP3ENPP1PPARGPPARACYP2C9
SCHEMBL25538206 0.94 ENPP3 (0.38) ENPP3ENPP1PPARGPPARACYP2C9
SCHEMBL25538794 0.94 ENPP3 (0.38) ENPP3ENPP1PPARGPPARACYP2C9
SCHEMBL25540379 0.94 ENPP3 (0.39) ENPP3ENPP1PPARGPPARACYP2C9
SCHEMBL25538213 0.94 ENPP3 (0.39) ENPP3ENPP1PPARGPPARACYP2C9
SCHEMBL25538207 0.93 ENPP3 (0.38) ENPP3ENPP1PPARGPPARACYP2C9
SCHEMBL25538796 0.93 ENPP1 (0.41) ENPP3ENPP1PPARGPPARACYP2C9
SCHEMBL25538787 0.93 ACACA (0.39) ENPP3ENPP1CYP2C9CYP2C19MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM ENPP3 1183/4885ENPP1 408/4885PPARG 3089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.